MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Tardive syndromes induced by coadministration of tramadol and sertralin

H. Sarac, N. Bozina, N. Henigsberg, L. Bagaric-Krakan (Zagreb, Croatia)

Meeting: 2017 International Congress

Abstract Number: 423

Keywords: Antidepressants, Tardive dyskinesia(TD)

Session Information

Date: Tuesday, June 6, 2017

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To illustrate the possible association of tardive syndromes (TS) and coadministration of tramadol and sertraline in three patients.

Background: TS is delayed onset of movement disorders, reported with the use of dopamine antagonists, but there are a number of nonneuroleptic compounds that are also associated with TS. Serotonin syndrome was reported rarely with the selective serotonin reuptake inhibitor (SSRI) and opioid analgesic; however, TS has not been reported in association of tramadol and SSRI.

Methods: We studied three patients, one with generalized dystonia, and the two other with oromandibular dyskinesia and parkinsonian syndrome, receiving long-term combined tramadol and sertraline therapy for depressive disorder due to a chronic pain. The Abnormal Involuntary Movement Scale was used to detect and to follow the severity of patient’s TS over time. Naranjo score was used for estimating the probability of adverse drug reactions. 

Results: TS occured after addition of tramadol to sertraline therapy. After discontinuation of offending drugs significant improvement was observed. Serotonin reuptake inhibition by sertraline, as well as increased serotonin release by tramadol probably increased central serotonergic transmission and possibly induced development of TS in these patients. Individual susceptibility may also play a role in the development of TS. An objective causality assesment showed that the addition of tramadol to sertraline therapy was probable cause of the adverse events.

Conclusions: Physicians must be aware of possible TS as side effect in patient taking combination of opioid analgesic and SSRI to prevent serious adverse events.

References:

  1. Houlihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann Pharmacother. 2004 Mar;38(3):411-3.
  2. Ripple MG, Pestaner JP, Levine BS, Smialek JE. Lethal combination of tramadol and multiple drugs affecting serotonin. Am J Forensic Med Pathol. 2000 Dec;21(4):370-4.

To cite this abstract in AMA style:

H. Sarac, N. Bozina, N. Henigsberg, L. Bagaric-Krakan. Tardive syndromes induced by coadministration of tramadol and sertralin [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/tardive-syndromes-induced-by-coadministration-of-tramadol-and-sertralin/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/tardive-syndromes-induced-by-coadministration-of-tramadol-and-sertralin/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley